INHIBIN

This brand name is authorized in Netherlands

Active ingredients

The drug INHIBIN contains one active pharmaceutical ingredient (API):

1 Hydroquinidine
UNII 31J3Q51T6L - HYDROQUININE

Hydroquinidine is a d-rotatory alkaloid derived from cinchiona bark. Hydroquinidine is a pharmaceutical agent that acts as a class I antiarrhythmic agent (Ia) in the heart. Hydroquinidine causes increased action potential duration, as well as a prolonged QT interval. Like all other class I antiarrhythmic agents, hydroquinidine primarily works by blocking the fast inward sodium current (INa). Hydroquinidine is also used for the treatment of Malaria.

Read about Hydroquinidine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M09AA01 Hydroquinine M Musculo-skeletal system → M09 Other drugs for disorders of the musculo-skeletal system → M09A Other drugs for disorders of the musculo-skeletal system → M09AA Quinine and derivatives
Discover more medicines within M09AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: NL Z-Index G-Standaard, PRK Identifier(s): 32751

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.